Keywords

Details

Category:

Articles

Type:

artykuł w czasopiśmie wyróżnionym w JCR

Published in:

Postępy Higieny i Medycyny Doświadczalnej no. 73, pages 269 - 281,
ISSN: 0032-5449

Language:

Polish

Publication year:

2019

Bibliographic description:

Zalewska-Piątek B., Piątek R., Krawczyk B., Olszewski M.: Patomechanizm zakażeń dróg moczowych wywoływanych przez uropatogenne szczepy E. coli// Postępy Higieny i Medycyny Doświadczalnej. -Vol. 73, (2019), s.269-281

DOI:

Digital Object Identifier (open in new tab) 10.5604/01.3001.0013.2022

Bibliography: test

1. Postepy Hig Med Dosw (online), 2019; tom 73: 269-281 open in new tab
2. Bradford P.A.: Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this im- portant resistance threat. Clin. Microbiol. Rev., 2001; 14: 933-951 open in new tab
3. Carnoy C., Moseley S.L.: Mutational analysis of receptor binding mediated by the Dr family of Escherichia coli adhesins. Mol. Micro- biol., 1997; 23: 365-379 open in new tab
4. Cassini A., Plachouras D., Eckmanns T., Abu Sin M., Blank H.P., Ducomble T., Haller S., Harder T., Klingeberg A., Sixtensson M., Ve- lasco E., Weiß B., Kramarz P, Monnet D.L., Kretzschmar M.E., Suetens C.: Burden of six healthcare-associated infections on European po- pulation health: estimating incidence-based disability-adjusted life years through a population prevalence-based modeling study. PLoS Med., 2016; 13: e1002150 open in new tab
5. Caza M., Kronstad J.W.: Shared and distinct mechanisms of iron acquisition by bacterial and fungal pathogens of humans. Front. Cell. Infect. Microbiol., 2013; 3: 80 open in new tab
6. Chassin C., Vimont S., Cluzeaud F., Bens M., Goujon J.M., Fer- nandez B., Hertig A., Rondeau E., Arlet G., Hornef M.W., Vandewalle A.: TLR4 facilitates translocation of bacteria across renal collecting duct cells. J. Am. Soc. Nephrol., 2008; 19: 2364-2374 open in new tab
7. Chaturvedi K.S., Hung C.S., Crowley J.R., Stapleton A.E., Hen- derson J.P.: The siderophore yersiniabactin binds copper to protect pathogens during infection. Nat. Chem. Biol., 2012; 8: 731-736 open in new tab
8. Chen Y.H., Ko W.C., Hsueh P.R.: Emerging resistance problems and future perspectives in pharmacotherapy for complicated uri- nary tract infections. Expert Opin. Pharmacother., 2013; 14: 587-596 open in new tab
9. Chenoweth C.E . , Gould C.V., Saint S.: Diagnosis, management, and prevention of catheter-associated urinary tract infections. In- fect. Dis. Clin. North Am., 2014; 28: 105-119 open in new tab
10. Chlabicz S., Leszczynska K., Lukas W., Gualco L., Schito G., Naber K.G.: Uncomplicated lower urinary tract infections in females -cli- nical aspects, aetiology and antimicrobial resistance epidemiology. Results of the ARESC (Antimicrobial Resistance Epidemiological Su- rvey on Cystitis) study in Poland and their implications for empiric therapy. Przegl. Epidemiol., 2011; 65: 345-51
11. Chromek M . , Slamová Z., Bergman P., Kovács L., Podracká L., Eh- rén I., Hökfelt T., Gudmundsson G.H., Gallo R.L., Agerberth B., Brau- ner A.: The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med., 2006; 12: 636-641 open in new tab
12. Chue-Gonçalves M., Custódio C.C., Pelayo J.S., Nakazato G., Ko- bayashi R.K.: New approach for detection of Escherichia coli invasion to HeLa cells. J. Microbiol. Methods, 2018; 152: 31-35 open in new tab
13. Conover M.S., Flores-Mireles A.L., Hibbing M.E., Dodson K., Hult- gren S.J.: Establishment and characterization of UTI and CAUTI in a mouse model. J. Vis. Exp., 2015; 100: e52892 open in new tab
14. Cunningham P.N., Wang Y., Guo R., He G., Quigg R.J.: Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J. Im- munol., 2004; 172: 2629-2635 open in new tab
15. Dhakal B.K., Mulvey M.A.: The UPEC pore-forming toxin α-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory, and survival pathways. Cell Host Microbe, 2012; 11: 58-69 open in new tab
16. Dodson K.W., Pinkner J.S., Rose T., Magnusson G., Hultgren S.J., Waksman G.: Structural basis of the interaction of the pyelonephritic E. coli adhesin to its human kidney receptor. Cell, 2001; 105: 733-743 open in new tab
17. Emödy L., Kerényi M., Nagy G.: Virulence factors of uropatho- genic Escherichia coli. Int. J. Antimicrob. Agents, 2003; 2: 29-33 open in new tab
18. Eto D.S., Sundsbak J.L., Mulvey M.A.: Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. Cell. Mi- crobiol., 2006; 8: 704-717 open in new tab
19. Flores-Mireles A.L., Walker J.N., Caparon M., Hultgren S.J.: Uri- nary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol., 2015; 13: 269-284 open in new tab
20. Foxman B.: Epidemiology of urinary tract infections: inci- dence, morbidity, and economic costs. Am. J. Med., 2002; 113 (Suppl. 1A): 5S-13S open in new tab
21. Foxman B.: The epidemiology of urinary tract infection. Nat. Rev. Urol., 2010; 7: 653-660 open in new tab
22. Foxman B.: Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect. Dis. Clin. North Am., 2014; 28: 1-13 open in new tab
23. Garau J.: Other antimicrobials of interest in the era of ex- tended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline. Clin. Microbiol. Infect., 2008; 14 (Suppl 1): 198-202 open in new tab
24. Garcia E.C., Brumbaugh A.R., Mobley H.L.: Redundancy and specificity of Escherichia coli iron acquisition systems during uri- nary tract infection. Infect. Immun., 2011; 79: 1225-1235 open in new tab
25. Garcia M.I., Jouve M., Nataro J.P., Gounon P., Le Bouguénec C.: Characterization of the AfaD-like family of invasins encoded by pathogenic Escherichia coli associated with intestinal and extra- intestinal infections. FEBS Lett., 2000; 479: 111-117 open in new tab
26. Garcia T.A., Ventura C.L., Smith M.A., Merrell D.S., O'Brien A.D.: Cytotoxic necrotizing factor 1 and hemolysin from uro- pathogenic Escherichia coli elicit different host responses in the murine bladder. Infect. Immun., 2013; 81: 99-109 open in new tab
27. Geibel S., Waksman G.: The molecular dissection of the chap- erone-usher pathway. Biochim. Biophys. Acta, 2014; 1843: 1559- 1567 open in new tab
28. Goluszko P., Moseley S.L., Truong L.D., Kaul A., Williford J.R., Selvarangan R., Nowicki S., Nowicki B.: Development of ex- perimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region pre- vented tubulointerstitial nephritis. J. Clin. Investig., 1997; 99: 1662-1672 open in new tab
29. Goluszko P., Niesel D., Nowicki B., Selvarangan R., Nowicki S., Hart A., Pawelczyk E., Das M., Urvil P., Hasan R.: Dr operon- associated invasiveness of Escherichia coli from pregnant patients with pyelonephritis. Infect. Immun., 2001; 69: 4678-4680 open in new tab
30. Goluszko P., Popov V., Selvarangan R., Nowicki S., Pham T., Nowicki B.J.: Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line. J. Infect. Dis., 1997; 176: 158-167 open in new tab
31. Guglietta A.: Recurrent urinary tract infections in women: risk factors, etiology, pathogenesis and prophylaxis. Future Mi- crobiol., 2017; 12: 239-246 open in new tab
32. Guignot J., Hudault S., Kansau I., Chau I., Servin A.L.: Human decay-accelerating factor and CEACAM receptor-mediated inter- nalization and intracellular lifestyle of Afa/Dr diffusely adhering Escherichia coli in epithelial cells. Infect. Immun., 2009; 77: 517-531 open in new tab
33. Gupta K., Bhadelia N.: Management of urinary tract infec- tions from multidrug-resistant organisms. Infect. Dis. Clin. North Am., 2014; 28: 49-59 open in new tab
34. Gupta K., Sahm D.F., Mayfield D., Stamm W.E.: Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: A nationwide analysis. Clin. Infect. Dis., 2001; 33: 89-94 open in new tab
35. Hannan T.J., Mysorekar I.U., Hung C.S., Isaacson-Schmid M.L., Hultgren S.J.: Early severe inflammatory responses to uropatho- genic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog., 2010; 6: e1001042 open in new tab
36. Hannan T.J., Totsika M., Mansfield K.J., Moore K.H., Schembri M.A., Hultgren S.J.: Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escheri- chia coli bladder infection. FEMS Microbiol. Rev., 2012; 36: 616-648 open in new tab
37. Hooton T.M.: Clinical practice. Uncomplicated urinary tract infection. N. Engl. J. Med., 2012; 366: 1028-1037 open in new tab
38. Zalewska-Piątek B. i wsp. -Patomechanizm zakażeń dróg moczowych...
39. Lo E., Nicolle L.E., Coffin S.E., Gould C., Maragakis L.L., Meddings J., Pegues D.A., Pettis A.M., Saint S., Yokoe D.S.: Strategies to prevent catheter-associated urinary tract infections in acute care hospitals. Infect. Control Hosp. Epidemiol., 2014; 35 (Suppl 2): S32-S47 open in new tab
40. Martinez J.J., Hultgren S.J.: Requirement of Rho-family GTPases in the invasion of Type 1-piliated uropathogenic Escherichia coli. Cell. Microbiol., 2002; 4: 19-28 open in new tab
41. Martinez J.J., Mulvey M.A., Schilling J.D., Pinkner J.S., Hultgren S.J.: Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J., 2000; 19: 2803-2812 open in new tab
42. Melican K . , Sandoval R.M., Kader A., Josefsson L., Tanner G.A., Molitoris B.A., Richter-Dahlfors A.: Uropathogenic Escherichia coli P and Type 1 fimbriae act in synergy in a living host to facilitate renal colonization leading to nephron obstruction. PLoS Pathog. 2011; 7: e1001298 open in new tab
43. Miao Y., Li G., Zhang X., Xu H., Abraham S.N.: A TRP channel senses lysosome neutralization by pathogens to trigger their expul- sion. Cell, 2015; 161: 1306-1319 open in new tab
44. Miao Y., Wu J., Abraham S.N.: Ubiquitination of innate immune regulator TRAF3 orchestrates expulsion of intracellular bacteria by exocyst complex. Immunity, 2016; 45: 94-105 open in new tab
45. Muenzner P., Kengmo Tchoupa A., Klauser B., Brunner T., Pu- tze J., Dobrindt U., Hauck C.R.: Uropathogenic E. coli exploit CEA to promote colonization of the urogenital tract mucosa. PLoS Pathog., 2016; 12: e1005608 open in new tab
46. Mulvey M.A., Lopez-Boado Y.S., Wilson C.L., Roth R., Parks W.C., Heuser J., Hultgren S.J.: Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science, 1998; 282: 1494-1497 open in new tab
47. Mulvey M.A., Schilling J.D., Hultgren S.J.: Establishment of a per- sistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect. Immun., 2001; 69: 4572-4579 open in new tab
48. Mysorekar I.U., Hultgren S.J.: Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc. Natl. Acad. Sci. USA, 2006; 103: 14170-14175 open in new tab
49. Naber K.G., Schito G., Botto H., Palou J., Mazzei T.: Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Re- sistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur. Urol., 2008; 54: 1164-1175 open in new tab
50. Nagamatsu K., Hannan T.J., Guest R.L., Kostakioti M., Hadjifran- giskou M., Binkley J., Dodson K., Raivio T.L., Hultgren S.J.: Dysregula- tion of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection. Proc. Natl. Acad. Sci. USA, 2015; 112: E871-E880 open in new tab
51. Nielsen K.L., Dynesen P., Larsen P., Jakobsen L., Andersen P.S., Frimodt-Møller N.: Role of urinary cathelicidin LL-37 and human β-defensin 1 in uncomplicated Escherichia coli urinary tract infec- tions. Infect. Immun., 2014; 82: 1572-1578 open in new tab
52. Nielubowicz G.R., Mobley H.L.: Host-pathogen interactions in urinary tract infection. Nat. Rev. Urol., 2010; 7: 430-441 open in new tab
53. Nowicki B., Moulds J., Hull R., Hull S.: A hemagglutinin of uro- pathogenic Escherichia coli recognizes the Dr blood group antigen. Infect. Immun., 1988; 56: 1057-1060 open in new tab
54. Nowicki B., Selvarangan R., Nowicki S.: Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and in- vasiveness. J. Infect. Dis., 2001; 183 (Suppl. 1): S24-S27 open in new tab
55. O'Brien V.P., Hannan T.J., Nielsen H.V., Hultgren S.J.: Drug and vaccine development for the treatment and prevention of urinary tract infections. Microbiol. Spectr., 2016; 4: 1-62 open in new tab
56. Oelschlaeger T.A., Dobrindt U., Hacker J.: Pathogenicity islands of uropathogenic E. coli and the evolution of virulence. Int. J. Anti- microb. Agents, 2002; 19: 517-521 open in new tab
57. Hung C.S., Bouckaert J., Hung D., Pinkner J., Widberg C., DeFus- co A., Auguste C.G., Strouse R., Langermann S., Waksman G., Hult- gren S.J.: Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. Mol. Microbiol., 2002; 44: 903-915 open in new tab
58. Hung C.S., Dodson K.W., Hultgren S.J.: A murine model of uri- nary tract infection. Nat. Protoc., 2009; 4: 1230-1243 open in new tab
59. Hunstad D.A., Justice S.S.: Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu. Rev. Mi- crobiol., 2010; 64: 203-221 open in new tab
60. Jacobsen S.M., Stickler D.J., Mobley H.L., Shirtliff M.E.: Com- plicated catheter-associated urinary tract infections due to Esche- richia coli and Proteus mirabilis. Clin. Microbiol. Rev., 2008; 21: 26-59 open in new tab
61. Justice S.S., Hung C., Theriot J.A., Fletcher D.A., Anderson G.G., Footer M.J., Hultgren S.J.: Differentiation and developmental path- ways of uropathogenic Escherichia coli in urinary tract pathogen- esis. Proc. Natl. Acad. Sci. USA, 2004; 101: 1333-1338 open in new tab
62. Justice S.S., Hunstad D.A.: UPEC hemolysin: more than just for making holes. Cell Host Microbe, 2012; 11: 4-5 open in new tab
63. Justice S.S., Hunstad D.A., Seed P.C., Hultgren S.J.: Filamenta- tion by Escherichia coli subverts innate defenses during urinary tract infection. Proc. Natl. Acad. Sci. USA, 2006; 103: 19884-19889 open in new tab
64. Kahlmeter G., Poulsen H.O.: Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited. Int. J. Antimicrob. Agents, 2012; 39: 45-51 open in new tab
65. Kline K.A., Schwartz D.J., Lewis W.G., Hultgren S.J., Lewis A.L.: Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection. Infect. Immun., 2011; 79: 3588-3595 open in new tab
66. Korhonen T.K, Parkkinen J., Hacker J., Finne J., Pere A., Rhen M., Holthöfer H.: Binding of Escherichia coli S fimbriae to human kidney epithelium. Infect. Immun., 1986; 54: 322-327 open in new tab
67. Korotkova N., Yang Y., Le Trong I., Cota E., Demeler B., March- ant J., Thomas W.E., Stenkamp R.E., Moseley S.L., Matthews S.: Bind- ing of Dr adhesins of Escherichia coli to carcinoembryonic antigen triggers receptor dissociation. Mol. Microbiol., 2008; 67: 420-434 open in new tab
68. Korotkova N., Yarova-Yarovaya Y., Tchesnokova V., Yazvenko N., Carl M.A., Stapleton A.E., Moseley S.L.: Escherichia coli DraE ad- hesin-associated bacterial internalization by epithelial cells is pro- moted independently by decay-accelerating factor and carcinoem- bryonic antigen-related cell adhesion molecule binding and does not require the DraD invasin. Infect. Immun., 2008; 76: 3869-3880 open in new tab
69. Kot B., Wicha J., Żak-Puławska Z.: Susceptibility of Escherichia coli strains isolated from persons with urinary tract infections in 2007-2008 to antimicrobial agents. Przegl. Epidemiol., 2010; 64: 307-312
70. Landraud L., Pulcini C., Gounon P., Flatau G., Boquet P., Lemi- chez E.: E. coli CNF1 toxin: a two-in-one system for host-cell inva- sion. Int. J. Med. Microbiol., 2004; 293: 513-518 open in new tab
71. Le Bouguénec C., Servin, A.L.: Diffusely adherent Escherichia coli strains expressing Afa/Dr adhesins (Afa/Dr DAEC): hitherto unrecognized pathogens. FEMS Microbiol. Lett., 2006; 256: 185-194 open in new tab
72. Leffler H., Svanborg-Edén C.: Glycolipid receptors for uro- pathogenic Escherichia coli on human erythrocytes and uroepithe- lial cells. Infect. Immun., 1981; 34: 920-929 open in new tab
73. Levison M.E., Kaye D.: Treatment of complicated urinary tract infections with an emphasis on drug-resistant gram-negative uro- pathogens. Curr. Infect. Dis. Rep., 2013; 15: 109-115 open in new tab
74. Lewis A.J. Richards A.C., Mulvey M.A.: Invasion of host cells and tissues by uropathogenic bacteria. Microbiol. Spectr., 2016; 4: 1-29 open in new tab
75. Lichtenberger P., Hooton T.M.: Complicated urinary tract in- fections. Curr. Infect. Dis. Rep., 2008; 10: 499-504 open in new tab
76. Postepy Hig Med Dosw (online), 2019; tom 73: 269-281 open in new tab
77. Song J., Bishop B.L., Li G., Duncan M.J., Abraham S.N.: TLR4- initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe, 2007; 1: 287-298 open in new tab
78. Song J., Bishop B.L., Li G., Grady R., Stapleton A., Abraham S.N.: TLR4-mediated expulsion of bacteria from infected bladder epithe- lial cells. Proc. Natl. Acad. Sci. USA, 2009; 106: 14966-14971 open in new tab
79. Spaulding C.N., Schreiber H.L. 4th, Zheng W., Dodson K.W., Ha- zen J.E., Conover M.S., Wang F., Svenmarker P., Luna-Rico A., France- tic O., Andersson M., Hultgren S., Egelman E.H.: Functional role of the type 1 pilus rod structure in mediating host-pathogen interac- tions. eLife, 2018; 7: e31662 open in new tab
80. Stamm W.E., Norrby S.R.: Urinary tract infections: disease pa- norama and challenges. J. Infect. Dis., 2001; 183 (Suppl 1): S1-S4 open in new tab
81. Terlizzi M.E., Gribaudo G., Maffei M.E.: UroPathogenic Esche- richia coli (UPEC) Infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front. Mi- crobiol., 2017; 8: 1566 open in new tab
82. Thankavel K., Madison B., Ikeda T., Malaviya R., Shah A.H., Aru- mugam P.M., Abraham S.N.: Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor reco- gnition and use of a domain-specific antibody to confer protection against experimental urinary tract infection. Clin. Invest., 1997; 100: 1123-1136 open in new tab
83. Thurston T.L., Wandel M.P., von Muhlinen N., Foeglein A., Ran- dow F.: Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature, 2012; 482: 414-418 open in new tab
84. Valdebenito M., Crumbliss A.L., Winkelmann G., Hantke K.: Environmental factors influence the production of enterobactin, salmochelin, aerobactin, and yersiniabactin in Escherichia coli strain Nissle 1917. Int. J. Med. Microbiol., 2006; 296: 513-520 open in new tab
85. Vallet I., Olson J.W., Lory S., Lazdunski A., Filloux A.: The cha- perone/usher pathways of Pseudomonas aeruginosa: identification of fimbrial gene clusters (cup) and their involvement in biofilm forma- tion. Proc. Natl. Acad. Sci. USA, 2001; 98: 6911-6916 open in new tab
86. Valore E.V., Park C.H., Quayle A.J., Wiles K.R., McCray P.B. Jr, Ganz T.: Human beta-defensin-1: an antimicrobial peptide of uro- genital tissues. J. Clin. Invest., 1998; 101: 1633-1642 open in new tab
87. Waksman G., Hultgren S.J.: Structural biology of the chape- rone-usher pathway of pilus biogenesis. Nat. Rev. Microbiol., 2009; 7: 765-774 open in new tab
88. Wankel B . , Ouyang J., Guo X., Hadjiolova K., Miller J., Liao Y., Tham D.K., Romih R., Andrade L.R., Gumper I., Simon J.P., Sachdeva R., Tolmachova T., Seabra M.C., Fukuda M. i wsp.: Sequential and compartmentalized action of Rabs, SNAREs, and MAL in the apical delivery of fusiform vesicles in urothelial umbrella cells. Mol. Biol. Cell, 2016; 27: 1621-1634 open in new tab
89. Watts R.E., Totsika M., Challinor V.L., Mabbett A.N., Ulett G.C., De Voss J.J., Schembri M.A.: Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli. Infect. Immun., 2012; 80: 333-344 open in new tab
90. Werneburg G.T., Thanassi D.G.: Pili assembled by the chape- rone/usher pathway in Escherichia coli and Salmonella. EcoSal Plus, 2018; 8: 1-37 open in new tab
91. Wróblewska-Seniuk K., Selvarangan R., Hart A., Pladzyk R., Goluszko P., Jafari A., du Merle L., Nowicki S., Yallampalli C., Le Bo- uguénec C., Nowicki B.: Dra/AfaE adhesin of uropathogenic Dr/Afa + Escherichia coli mediates mortality in pregnant rats. Infect. Immun., 2005; 73: 7597-7601 open in new tab
92. Wurpel D.J., Beatson S.A., Totsika M, Petty N.K., Schembri M.A.: Chaperone-usher fimbriae of Escherichia coli. PLoS One, 2013; 8: e52835 open in new tab
93. Yamamoto S.: Molecular epidemiology of uropathogenic Esche- richia coli. J. Infect. Chemother., 2007; 13: 68-73 open in new tab
94. Paterson D.L.: Resistance in gram-negative bacteria: Enterobac- teriaceae. Am. J. Infect. Control, 2006; 34 (5 Suppl 1): S20-S28 open in new tab
95. Pendleton J.N., Gorman S.P., Gilmore B.F.: Clinical relevance of the ESKAPE pathogens. Expert Rev. Anti Infect. Ther., 2013; 11: 297-308 open in new tab
96. Pere A., Leinonen M., Väisänen-Rhen V., Rhen M., Korhonen T.K.: Occurrence of type-1C fimbriae on Escherichia coli strains iso- lated from human extraintestinal infections. J. Gen. Microbiol., 1985; 131: 1705-1711 open in new tab
97. Piątek R., Zalewska B., Kolaj O., Ferens M., Nowicki B., Kur J.: Mo- lecular aspects of biogenesis of Escherichia coli Dr fimbriae: charac- terization of DraB-DraE complexes. Infect. Immun., 2005; 73: 135-145
98. Raz R., Gennesin Y., Wasser J., Stoler Z., Rosenfeld S., Rotten- sterich E., Stamm W.E.: Recurrent urinary tract infections in post- menopausal women. Clin. Infect. Dis., 2000; 30: 152-156 open in new tab
99. Reigstad C.S., Hultgren S.J., Gordon J.I.: Functional genomic studies of uropathogenic Escherichia coli and host urothelial cells when intracellular bacterial communities are assembled. J. Biol. Chem., 2007; 282: 21259-21267 open in new tab
100. Roberts J.A., Marklund B.I., Ilver D., Haslam D., Kaack M.B., Baskin G., Louis, M., Möllby R., Winberg J., Normark S.: The Gal(alpha open in new tab
101. Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. Proc. Natl. Acad. Sci. USA, 1994; 91: 11889-11893 open in new tab
102. Robino L., Scavone P., Araujo L., Algorta G., Zunino P., Pírez M.C., Vignoli R.: Intracellular bacteria in the pathogenesis of Esche- richia coli urinary tract infection in children. Clin. Infect. Dis., 2014; 59: e158-e164 open in new tab
103. Rogers B.A., Sidjabat H.E., Paterson D.L.: Escherichia coli O25b- ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother., 2011; 66: 1-14 open in new tab
104. Ronald A.: The etiology of urinary tract infection: traditional and emerging pathogens. Dis. Mon., 2003; 49: 71-82 open in new tab
105. Rosen D.A., Hooton T.M., Stamm W.E., Humphrey P.A., Hultgren S.J.: Detection of intracellular bacterial communities in human uri- nary tract infection. PLoS Med., 2007; 4: e329 open in new tab
106. Russo T.A., Stapleton A., Wenderoth S., Hooton T.M., Stamm W.E.: Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women. J. Infect. Dis., 1995; 172: 440-445 open in new tab
107. Salvatore S., Salvatore S., Cattoni E., Siesto G., Serati M., Sorice P., Torella M.: Urinary tract infections in women. Eur. J. Obstet. Gy- necol. Reprod. Biol., 2011; 156: 131-136 open in new tab
108. Scholes D., Hooton T.M., Roberts P.L. Stapleton A.E., Gupta K., Stamm W.E.: Risk factors for recurrent urinary tract infection in young women. J. Infect. Dis., 2000; 182: 1177-1182 open in new tab
109. Schwartz D.J., Chen S.L., Hultgren S.J., Seed P.C.: Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection. Infect. Immun., 2011; 79: 4250-4259 open in new tab
110. Selvarangan R., Goluszko P., Singhal J., Carnoy C., Moseley S., Hudson B., Nowicki S., Nowicki B.: Interaction of Dr adhesin with collagen type IV is a critical step in Escherichia coli renal persistence. Infect. Immun., 2004; 72: 4827-4835 open in new tab
111. Servin A.L.: Pathogenesis of Afa/Dr diffusely adhering Escheri- chia coli. Clin. Microbiol. Rev., 2005; 18: 264-292 open in new tab
112. Smaill F., Vazquez J.C.: Antibiotics for asymptomatic bacteri- uria in pregnancy. Cochrane Database Syst. Rev., 2007; 2: CD000490 open in new tab
113. Sokurenko E.V., Chesnokova V., Doyle R.J, Hasty D.L.: Diversity of the Escherichia coli type 1 fimbrial lectin. Differential binding to mannosides and uroepithelial cells. J. Biol. Chem., 1997; 272: 17880-17886 open in new tab
114. Zalewska-Piątek B. i wsp. -Patomechanizm zakażeń dróg moczowych...
115. Zavialov A., Zav'yalova G., Korpela T., Zav'yalov V.: FGL chapero- ne-assembled fimbrial polyadhesins: anti-immune armament of Gram- -negative bacterial pathogens. FEMS Microbiol. Rev., 2007; 31: 478-514 open in new tab
116. Zowawi H.M., Harris P.N., Roberts M.J., Tambyah P.A., Schembri M.A., Pezzani M.D., Williamson D.A., Paterson D.L.: The emerging thre- at of multidrug-resistant Gram-negative bacteria in urology. Nat. Rev. Urol., 2015; 12: 570-584 open in new tab
117. Autorzy deklarują brak potencjalnych konfliktów inte- resów. open in new tab
118. Zalewska-Piątek B., Bury K., Piątek R., Bruździak P., Kur J.: Type II secretory pathway for surface secretion of DraD invasin from the uropathogenic Escherichia coli Dr + strain. J. Bacteriol., 2008; 190: 5044-5056 open in new tab
119. Zalewska-Piątek B., Piątek R., Olszewski M., Kur J.: Identifi- cation of antigen Ag43 in uropathogenic Escherichia coli Dr + strains and defining its role in the pathogenesis of urinary tract infections. Microbiology, 2015; 161:1034-1049 open in new tab
120. Zalewska Piątek B.M., Wilkanowicz S.I., Piątek R.J., Kur J.W.: Bio- film formation as a virulence determinant of uropathogenic Escheri- chia coli Dr + strains. Pol. J. Microbiol., 2009; 58: 223-229

show (120) hide

Sources of funding:

• Statutory activity/subsidy

Verified by:

Gdańsk University of Technology